A Double-Blind, Randomized, Placebo-Controlled, Phase 2 Trial of YKP3089 as Adjunctive Therapy in Subjects With Partial Onset Seizures

Clinical trial NCT01866111 · COMPLETED

Trial details

NCT number: NCT01866111
Sponsor: SK Life Science, Inc.
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Partial Epilepsy

Start date: 2013-07-31
Primary completion: 2021-04-05
Enrollment: 437

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.